BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21851533)

  • 1. Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma.
    Donin NM; Suh LK; Barlow L; Hruby GW; Newhouse J; McKiernan J
    BJU Int; 2012 Feb; 109(3):379-83. PubMed ID: 21851533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.
    Jeon HG; Gong IH; Hwang JH; Choi DK; Lee SR; Park DS
    BJU Int; 2012 May; 109(10):1468-73. PubMed ID: 21883863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma.
    Jeon HG; Choo SH; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Eur J Cancer; 2014 Jan; 50(1):64-9. PubMed ID: 24060356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid levels correlate with baseline renal function and high levels are a potent risk factor for postoperative chronic kidney disease in patients with renal cell carcinoma.
    Jeon HG; Choo SH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Urol; 2013 Apr; 189(4):1249-54. PubMed ID: 23159461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor size on renal function and prediction of renal insufficiency after radical nephrectomy in patients with renal cell carcinoma.
    Ohno Y; Nakashima J; Ohori M; Hashimoto T; Iseki R; Hatano T; Tachibana M
    J Urol; 2011 Oct; 186(4):1242-6. PubMed ID: 21849191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same.
    Hew MN; Opondo D; Cordeiro ER; van Donselaar-van der Pant KA; Bemelman FJ; Idu MM; de la Rosette JJ; Laguna MP
    BJU Int; 2014 May; 113(5b):E49-55. PubMed ID: 24053637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis.
    Barlow LJ; Korets R; Laudano M; Benson M; McKiernan J
    BJU Int; 2010 Aug; 106(4):489-92. PubMed ID: 20039869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
    Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
    BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
    Jeldres C; Bensalah K; Capitanio U; Zini L; Perrotte P; Suardi N; Tostain J; Valeri A; Descotes JL; Rambeaud JJ; de La Taille A; Salomon L; Abbou C; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Jun; 103(12):1632-5. PubMed ID: 19545272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tumour anatomical characteristics and functional outcome after partial nephrectomy.
    Nisen H; Heimonen P; Kenttä L; Visapää H; Nisen J; Taari K
    Scand J Urol; 2015 Jun; 49(3):193-9. PubMed ID: 25385687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological tumour diameter predicts risk of conventional subtype in small renal cortical tumours.
    Laudano MA; Klafter FE; Katz M; McCann TR; Desai M; Benson MC; McKiernan JM
    BJU Int; 2008 Nov; 102(10):1385-8. PubMed ID: 18710458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tumour morphology on renal function decline after partial nephrectomy.
    Mehrazin R; Palazzi KL; Kopp RP; Colangelo CJ; Stroup SP; Masterson JH; Liss MA; Cohen SA; Jabaji R; Park SK; Patterson AL; L'Esperance JO; Derweesh IH
    BJU Int; 2013 Jun; 111(8):E374-82. PubMed ID: 23714649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy.
    Malcolm JB; Bagrodia A; Derweesh IH; Mehrazin R; Diblasio CJ; Wake RW; Wan JY; Patterson AL
    BJU Int; 2009 Aug; 104(4):476-81. PubMed ID: 19220252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
    Stern JM; Gupta A; Raman JD; Cost N; Lucas S; Lotan Y; Raj GV; Cadeddu JA
    BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic potential of a renal mass according to original tumour size at presentation.
    Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
    BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of radical and partial nephrectomy in terms of renal function: a retrospective cohort study.
    Süer E; Burgu B; Gökce Mİ; Türkölmez K; Bedük Y; Baltaci S
    Scand J Urol Nephrol; 2011 Feb; 45(1):24-9. PubMed ID: 20923383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function outcomes after nephrectomy for kidney cancer in elderly patients.
    Markić D; Valencić M; Spanjol J; Materljan M; Fuckar D
    Coll Antropol; 2011 Sep; 35 Suppl 2():121-4. PubMed ID: 22220418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.